ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,168.37
-1.79%
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs Yen
156.221
-0.10%
Brent Oil
82.445
-1.30%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Immunovia Ab (publ) (0G8X)

  7. Immunovia Ab (publ) (0G8X) ニュース

0G8X

Immunovia Ab (publ) (0G8X)

Immunovia Ab (publ)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:0G8X
日付受信時刻ニュースソース見出しコード企業名
2024/01/0500 : 59PR Newswire (US)Immunovia announces financial calendar for financial year 2024LSE:0G8XImmunovia Ab (publ)
2024/01/0500 : 58PR Newswire (US)Immunovia announces financial calendar for financial year 2024LSE:0G8XImmunovia Ab (publ)
2023/11/2119 : 40PR Newswire (US)Bulletin from the extraordinary general meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
2023/11/2119 : 38PR Newswire (US)Bulletin from the extraordinary general meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
2023/11/0917 : 03PR Newswire (US)Immunovia Publishes Interim Report for January-September 2023LSE:0G8XImmunovia Ab (publ)
2023/11/0916 : 59PR Newswire (US)Immunovia Publishes Interim Report for January-September 2023LSE:0G8XImmunovia Ab (publ)
2023/11/0800 : 14PR Newswire (US)Immunovia successfully completes discovery phase of next-generation test developmentLSE:0G8XImmunovia Ab (publ)
2023/11/0800 : 12PR Newswire (US)Immunovia successfully completes discovery phase of next-generation test developmentLSE:0G8XImmunovia Ab (publ)
2023/11/0219 : 02PR Newswire (US)Invitation to Immunovia's Q3 presentationLSE:0G8XImmunovia Ab (publ)
2023/11/0219 : 00PR Newswire (US)Invitation to Immunovia's Q3 presentationLSE:0G8XImmunovia Ab (publ)
2023/10/2716 : 06PR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)LSE:0G8XImmunovia Ab (publ)
2023/10/2716 : 03PR Newswire (US)CONVENING NOTICE - EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)LSE:0G8XImmunovia Ab (publ)
2023/10/0318 : 01PR Newswire (US)Nomination Committee appointed for Immunovia AB (Publ)LSE:0G8XImmunovia Ab (publ)
2023/10/0317 : 56PR Newswire (US)Nomination Committee appointed for Immunovia AB (Publ)LSE:0G8XImmunovia Ab (publ)
2023/08/3019 : 30PR Newswire (US)Immunovia Publishes Interim Report for January-June 2023LSE:0G8XImmunovia Ab (publ)
2023/08/3015 : 56PR Newswire (US)Immunovia Publishes Interim Report for January-June 2023LSE:0G8XImmunovia Ab (publ)
2023/08/2403 : 08PR Newswire (US)Invitation to Immunovia's Q2 presentationLSE:0G8XImmunovia Ab (publ)
2023/08/2403 : 06PR Newswire (US)Invitation to Immunovia's Q2 presentationLSE:0G8XImmunovia Ab (publ)
2023/07/2001 : 47PR Newswire (US)Immunovia announces updated financial calendarLSE:0G8XImmunovia Ab (publ)
2023/07/1216 : 15PR Newswire (US)Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer DetectionLSE:0G8XImmunovia Ab (publ)
2023/07/1216 : 12PR Newswire (US)Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer DetectionLSE:0G8XImmunovia Ab (publ)
2023/06/0917 : 19PR Newswire (US)Chief Executive Officer, Jeff Borcherding, buys Immunovia sharesLSE:0G8XImmunovia Ab (publ)
2023/06/0917 : 11PR Newswire (US)Chief Executive Officer, Jeff Borcherding, buys Immunovia sharesLSE:0G8XImmunovia Ab (publ)
2023/05/3119 : 16PR Newswire (US)Change in number of shares and votes in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
2023/05/3119 : 13PR Newswire (US)Change in number of shares and votes in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
2023/05/2620 : 43PR Newswire (US)Bulletin from the Annual General Meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
2023/05/2620 : 41PR Newswire (US)Bulletin from the Annual General Meeting in Immunovia ABLSE:0G8XImmunovia Ab (publ)
2023/05/2316 : 03PR Newswire (US)Immunovia Publishes Interim Report for January-March 2023LSE:0G8XImmunovia Ab (publ)
2023/05/2316 : 00PR Newswire (US)Immunovia Publishes Interim Report for January-March 2023LSE:0G8XImmunovia Ab (publ)
2023/05/2301 : 55PR Newswire (US)Changes to the Nomination Committee's proposal to the Annual General Meeting 2023 in Immunovia AB (publ)LSE:0G8XImmunovia Ab (publ)
 Showing the most relevant articles for your search:LSE:0G8X

最近閲覧した銘柄

FX
USDJPY
US Dollar vs Yen
USI
USTECH100
US Tech 100
USOTC
ADDYY
Adidas (QX)
CCOM
US100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
MSFT
Microsoft
CCOM
US30
US 30
FX
USDEUR
US Dollar vs Euro
AMEX
SPY
SPDR S&P 500
USOTC
BASFY
BASF (QX)
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
COIN
SOLUSD
Solana
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有